NEW YORK, May 4 (GenomeWeb News) - Exiqon today said that IBA, a Goettingen, Germany-based life science tool provider, has licensed its Locked Nucleic Acid (LNA) technology for resale in the genomics research market.

IBA (originally founded as the non-profit Institut f r Bioanalytik) acquired non-exclusive rights to manufacture and sell LNA oligonucleotides.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

Under a proposed spending bill, the US National Institutes of Health would see an additional $3 billion in funding.

Researchers from the University of Oxford and the University of Sydney sequenced numerous platypus genomes to study their population history.

Robert Redfield, the new pick to lead the US Centers for Disease Control and Prevention, has faced criticism for some of his work.

In Nature this week: sequenced genomes of five additional Neanderthals, and more.